Capital markets

Baker McKenzie

Baker McKenzie’s Stockholm office sits at the forefront of the equity capital markets space in Sweden, with the team regularly handling IPOs, including on Nasdaq Stockholm and Nasdaq First North Growth Market, as well as rights issuances, ABBs, and public takeovers. The group is regularly instructed by domestic and international investment banks as underwriters’ counsel and is also noted for its life sciences expertise; acting for several banks in relation to Cinclus Pharma’s main market mid-segment IPO is a recent highlight for the team. Practice head Joakim Falkner has considerable experience representing late-stage private and publicly traded companies, investment banks, investors, shareholders, and sponsors on pre-IPO transactions, IPOs, primary share issuances, and preferential rights offerings. Henric Roth is active in the tech and life sciences spaces. Stefan Balazs and senior associate Johanna Flink are also key contacts.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘A detail- and solution-oriented team that is also very knowledgeable.'
‘Joakim Falkner is very easy to work with, pragmatic without loss of legal focus and always ready to go the extra mile. He and the rest of the team makes any transaction a smooth ride. Johanna Flink is a very experienced lawyer, always available and result-oriented, which make intense transaction processes work smoothly.’
‘Joakim Falkner is very experienced in the field. Henric Roth is easy to work with, with a client friendly and pragmatic approach to problem solving. Stefan Balazs is knowledgeable and easy to work with.'
‘Joakim Falkner is pragmatic and very knowledgeable.’
‘The capital markets team is very flexible and always available for any situation. They are quick to respond and provide an excellent service on any given day. The team is extremely competent and qualified within the capital markets area, handling complex matters in a very good way by offering a constructive dialogue and direct and hands-on approach with a great sense of market practice.’
‘A team with high competence, availability and creativity.’
‘One of the most experienced teams in ECM in the market with good knowledge of market trends.'
‘The team is very accessible and quick to provide focused and correct legal advice.’

Work highlights

Advised Olink Holding AB (publ), a leader in next generation proteomics, on its sale to Thermo Fisher Scientific on an all-cash transaction valued at approximately $3.1bn (including net cash).
Acted for the investment banks in the SEK3bn primary issuance of shares in Catena AB, listed on Nasdaq Stockholm.
Acting for Carnegie, Handelsbanken and Nordea on the SEK1.25bn rights issue by Nobia AB, listed on Nasdaq Stockholm.